High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer
Authors:
Open Access
- 22 September 2016
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (5) , 3825-3835
Abstract
Poly (adenosine diphosphate‑ribose) polymerase 1 (PARP-1) was previously demonstrated to be overexpressed in numerous malignant tumors and associated with invasiveness and poor prognosis. However, the expression of the PARP‑1 protein in gastric cancer and its association with clinical outcomes requires further investigation. In the present study, the expression of PARP‑1 in 564 gastric cancer tissues and 335 tumor‑adjacent control tissues is investigated, using tissue microarray‑based immunohistochemistry. PARP‑1 expression levels were demonstrated to be significantly higher in gastric cancer tissue samples, as compared with control tissue samples. In gastric cancer, high PARP‑1 expression levels were significantly associated with Helicobacter pylori (H. pylori) infection (P=0.032), decreased differentiation (P<0.001), increased depth of invasion (P=0.037), presence of lymphatic invasion (P<0.001), presence of lymph node metastasis (P<0.001), and advanced tumor‑node‑metastasis (TNM) stage (P=0.015). High PARP‑1 expression levels were associated with a significantly shorter overall survival rate (P<0.001) and disease‑free survival rate (P=0.001) in patients with gastric cancer, particularly a subset of patients with H. pylori infection or an advanced TNM stage. In addition, univariate analysis indicated that PARP‑1 high expression levels were significantly associated with a poor prognosis in gastric cancer. These results suggest that PARP‑1 expression may be involved in the progression and prognosis of gastric cancer, particularly H. pylori‑positive or advanced‑stage gastric cancer.Keywords
This publication has 52 references indexed in Scilit:
- PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant TransformationPLOS Genetics, 2013
- The Role of Nuclear Matrix Proteins Binding to Matrix Attachment Regions (MARs) in Prostate Cancer Cell DifferentiationPLOS ONE, 2012
- A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and LymphomasClinical Cancer Research, 2012
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast CancerNew England Journal of Medicine, 2011
- Targeting poly(ADP-ribose) polymerase activity for cancer therapyCellular and Molecular Life Sciences, 2010
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical TargetsMolecular Cell, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- PARP inhibition: PARP1 and beyondNature Reviews Cancer, 2010
- Activation of the abundant nuclear factor poly(ADP-ribose) polymerase-1 by Helicobacter pyloriProceedings of the National Academy of Sciences, 2009
- The expanding field of poly(ADP‐ribosyl)ation reactionsEMBO Reports, 2008